feed rss
Star Alliance



ROOM ÜSKÜDAR        14:30 - 16:00



Biological  targets for treatment of glomerular diseases

Chairs: Peter Boor, Aachen, Germany
            Fernando Fervenza, Rochester, USA

- Anti CD20: emerging treatment  strategies of immune-mediated glomerular disease
Fernando  Fervenza,  Rochester, USA
- Anti-IL-6, anti-IL-1 and belimumab  - treatment options for glomerular disease?
Andreas  Schwarting,  Mainz, Germany

- Epidermal Growth Factor receptor  pathway as a potential target for the treatment of renal diseases Pierre-Louis  Tharaux,  Paris, France

back to the timetable

final programme "day by day" - may 18 - 21, 2013